Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
CC transcript
INCYTE CORP (INCY) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 8-K Quarterly results
05/08/2023 8-K Other Events  Interactive Data
05/02/2023 8-K Quarterly results
02/07/2023 8-K Quarterly results
Docs: "Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs"
11/01/2022 8-K Quarterly results
10/04/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/02/2022 8-K Quarterly results
Docs: "Conference Call and Webcast Scheduled Today at 8:00 a.m. EDT"
06/16/2022 8-K Quarterly results
05/03/2022 8-K Quarterly results
04/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/08/2022 8-K Quarterly results
01/14/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/02/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Statement Regarding Opzelura™ Cream WILMINGTON, Del. – November 2, 2021 – This morning, as part of our Q3 2021 earnings call, we addressed a question related to samples and commercial supply of Opzelura™ cream. As of today, we have received three product complaints related to texture. As is standard with a product report of this kind, we are following all regulations and protocols including informing the U.S. Food and Drug Administration, investigating the complaints and conducting a thorough root cause analysis across all batches to ensure continued product quality and supply. Early analytical testing of both the 5 gram and 60 gram batches of Opzelura in question do not show any issues that would impact the safety or efficacy of the product. The texture issue is rela..."
11/02/2021 8-K Quarterly results
Docs: "Conference Call and Webcast Scheduled Today at 8:00 a.m. EDT"
09/28/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/20/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
08/03/2021 8-K Quarterly results
Docs: "Conference Call and Webcast Scheduled Today at 8:00 a.m. EDT"
05/27/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
02/19/2021 8-K Quarterly results
02/09/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Incyte Reports 2020 Third Quarter Financial Results and Provides Updates on Key Clinical Programs"
08/04/2020 8-K Quarterly results
05/27/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "1997 EMPLOYEE STOCK PURCHASE PLAN OF INCYTE CORPORATION"
05/14/2020 8-K Quarterly results
05/05/2020 8-K Quarterly results
04/20/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/26/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/13/2020 8-K Quarterly results
01/16/2020 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab"
12/19/2019 8-K Quarterly results
10/29/2019 8-K Quarterly results
07/30/2019 8-K Quarterly results
Docs: "Incyte Reports 2019 Second Quarter Financial Results and Provides Updates on Key Clinical Programs"
04/30/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "The following Directors were elected:"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy